Navicixizumab
Product Specifications
CAS Number
1638338-43-8
Target
Gamma-secretase
Related Pathways
Stem Cells, Neuroscience, Proteases/Proteasome
Bioactivity
Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody that can be combined with Paclitaxel for cancer research, particularly in studies of ovarian, primary peritoneal, or fallopian tube cancer [1] [2] [3].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2887223-01 48 Well
Bovine Membrane primary amine oxidase ELISA Kit
Sign In for Pricing
View Details MBS2887223-02 96 Well
Bovine Membrane primary amine oxidase ELISA Kit
Sign In for Pricing
View Details MBS2887223-03 5x 96 Well
Bovine Membrane primary amine oxidase ELISA Kit
Sign In for Pricing
View Details MBS2887223-04 10x 96 Well
Bovine Membrane primary amine oxidase ELISA Kit
Sign In for Pricing
View Details sc-429617-LAC-2 200 µL
CRISP-4 Lentiviral Activation Particles (m2)
Sign In for Pricing
View Details